Leading the Way in Life Science Technologies

GEN Exclusives

More »

Companies

More »

Gamma Therapeutics

  • Gamma Therapeutics
  • 2611 SW Third Avenue, Suite 280N
  • Portland , 97201
  • None

Gamma Therapeutics is an early stage biotechnology venture developing solutions for cardiovascular disease risk assessment, biosurgical therapy and combat casualty care based upon the use of human biocompatible proteins, such as Gamma Prime Fibrinogen, responsible for the clotting mechanism in human blood. The product line includes its patent-pending flagship product, GammaCoeur™, a cardiovascular disease risk assessment assay; GammaSeal™, a patented, high strength surgical incision and wound healing sealant; Gammarin™, a patented anticoagulant blood thinner for use during and after surgery, and; GammaTF, a provisionally-patented fast-clotting hemostatic dressing for hemorrhage control.

 

Related To This Company